BPD
MCID: BRN056
MIFTS: 48

Bronchopulmonary Dysplasia (BPD) malady

Categories: Rare diseases, Respiratory diseases, Fetal diseases

Aliases & Classifications for Bronchopulmonary Dysplasia

About this section
Sources:
31ICD10 via Orphanet, 35LifeMap Discovery®, 40MESH via Orphanet, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Bronchopulmonary Dysplasia:

Name: Bronchopulmonary Dysplasia 35 48 54 50 68
 
Bpd 48 54

Characteristics:

Orphanet epidemiological data:

54
bronchopulmonary dysplasia:
Inheritance: Not applicable; Prevalence: 1-5/10000 (Europe); Age of onset: Infancy,Neonatal; Age of death: normal life expectancy

Classifications:



External Ids:

Orphanet54 ORPHA70589
MESH via Orphanet40 D001997
UMLS via Orphanet69 C0006287
ICD10 via Orphanet31 P27.1

Summaries for Bronchopulmonary Dysplasia

About this section
Wikipedia:71 Bronchopulmonary dysplasia (BPD; formerly chronic lung disease of infancy) is a chronic lung disorder of... more...

MalaCards based summary: Bronchopulmonary Dysplasia, also known as BPD, is related to borderline personality disorder and pulmonary hypertension, neonatal. An important gene associated with Bronchopulmonary Dysplasia is SCGB1A1 (Secretoglobin Family 1A Member 1), and among its related pathways are Interleukin-10 signaling and Interleukin-4 and 13 signaling. Affiliated tissues include lung, endothelial and brain, and related mouse phenotypes are neoplasm and cardiovascular system.

Related Diseases for Bronchopulmonary Dysplasia

About this section

Diseases related to Bronchopulmonary Dysplasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 87)
idRelated DiseaseScoreTop Affiliating Genes
1borderline personality disorder11.4
2pulmonary hypertension, neonatal10.9
3bronchial disease10.9
4pulmonary hypertension10.4
5chromophobe adenoma10.3CXCL8, SELL
6partial atrioventricular canal10.2SCGB1A1, SFTPB
7chorioamnionitis10.2
8endotheliitis10.2
9penis squamous cell carcinoma10.2SCGB1A1, SFTPB
10coronary arterial fistulas10.2CXCL8, IL1RN
11scleroderma, familial progressive10.2CXCL8, ELANE
12adnp syndrome10.2CXCL8, ELANE, SFTPB
13cardiomyopathy diabetes deafness10.2CXCL8, ELANE
14esophagus lymphoma10.2CXCL8, SCGB1A1, SFTPB
15benign focal seizures of adolescence10.1ELANE, TIMP1
16baritosis10.1CXCL8, SCGB1A1, SOD1
17lung disease10.1
18autoimmune polyendocrine syndrome type 110.1CXCL8, TIMP1
19personality disorder10.1
20skin conditions10.1CXCL8, IL1RN, SCGB1A1
21mitochondrial dna depletion syndrome 4b10.1FGF10, RBP4
22nervous system cancer10.1CXCL8, SFTPB, TIMP1
23nablus mask-like facial syndrome10.1ITGAM, SELL
24anogenital venereal wart10.1ELANE, SCGB1A1, SFTPB
25bone angioendothelial sarcoma10.1CXCL8, IL1RN, TIMP1
26burns10.1CXCL8, SCGB1A1, TIMP1
27infancy electroclinical syndrome10.1CXCL8, ELANE, FLT1
28hyperuricemia, pulmonary hypertension, renal failure, and alkalosis10.1ELANE, SELL, TIMP1
29pleural tuberculosis10.0FLT1, SOD1
30patent ductus arteriosus10.0
31major depressive disorder and accelerated response to antidepressant drug treatment10.0CXCL8, ELANE, ITGAM
32subcorneal pustular dermatosis10.0CXCL8, ELANE, SFTPB
33rectum squamous cell carcinoma10.0CXCL8, ELANE, SCGB1A1, SFTPB
34eating disorder10.0ELANE, ITGAM, SELL
35perrault syndrome10.0ITGAM, SELL, TIMP1
36xerophthalmia10.0ITGAM, SELL, TIMP1
37optic nerve glioma10.0ELANE, RNASE3
38histiocytosis10.0CXCL8, ELANE, IL1RN, TIMP1
39infectious anterior uveitis10.0CXCL8, ELANE, RNASE3
40intratubular embryonal carcinoma10.0CXCL8, ELANE, IL1RN, TIMP1
41omsk hemorrhagic fever10.0CXCL8, ELANE, ITGAM, SELL
42retinitis pigmentosa 5110.0CXCL8, ELANE, RNASE3
43familial renal papillary carcinoma9.9CXCL8, ELANE, RNASE3
44spontaneous ocular nystagmus9.9CXCL8, ELANE, RNASE3
45respiratory failure9.9
46acute chest syndrome9.9CXCL8, ELANE, RNASE3
47cycloplegia9.9ELANE, FLT1
48malignant peritoneal solitary fibrous tumor9.9CXCL8, RNASE3, SCGB1A1
49wilson-mikity syndrome9.9
50bare lymphocyte syndrome, type i9.8CXCL8, ELANE, IL1RN, RNASE3

Graphical network of the top 20 diseases related to Bronchopulmonary Dysplasia:



Diseases related to bronchopulmonary dysplasia

Symptoms & Phenotypes for Bronchopulmonary Dysplasia

About this section

MGI Mouse Phenotypes related to Bronchopulmonary Dysplasia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.6ELANE, SCGB1A1, SELL, SOD1, TIMP1
2MP:00053858.4FGF10, FLT1, IL1RN, RBP4, SELL, SOD1
3MP:00053977.8ELANE, FGF10, FLT1, IL1RN, ITGAM, SELL
4MP:00053877.4ELANE, FGF10, FLT1, IL1RN, ITGAM, SCGB1A1
5MP:00053766.9ELANE, FGF10, FLT1, IL1RN, ITGAM, RBP4

Drugs & Therapeutics for Bronchopulmonary Dysplasia

About this section

FDA approved drugs:

id Drug Name Active Ingredient(s)16 Company Approval Date
1
RespiGam16 MedImmune January 1996
FDA Label: -
Disease/s that Drug Treats:RSV, bronchopulmonary dysplasia
Indications and Usage:16 -
DrugBank Targets: -
Mechanism of Action:16 
Target: -
Action: -
FDA: -

Drugs for Bronchopulmonary Dysplasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 214)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
BudesonideapprovedPhase 4, Phase 3, Phase 2, Phase 143251333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide MMX
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
Horacort
 
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
2Poractant alfaapprovedPhase 4, Phase 2, Phase 326129069-19-8
3
ProcaterolapprovedPhase 43572332-33-3688561
Synonyms:
(R*,S*)-(+-)-8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone
5-[1-hydroxy-2-(propan-2-ylamino)butyl]quinoline-2,8-diol
60443-17-6
62929-91-3 (mono-hydrochloride)
72332-33-3
8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone
8-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one
AC-13705
AC1L1J8G
AC1Q6I3X
AR-1J3938
BRD-A22684332-003-02-3
BSPBio_003239
CHEMBL160519
CI-888
CID4916
D08424
EINECS 276-590-0
KBio3_002739
L023776
 
LS-142797
Meptin
Meptin (TN)
MolPort-005-934-511
NSC 308904
NSC308904
OPC-2009
PROCATEROL
Pro-Air
Procaterol (INN)
Procaterol Monohydrochloride
Procaterol [INN:BAN]
Procaterolo
Procaterolo [DCIT]
Procaterolum
Procaterolum [INN-Latin]
Procaterolum [Latin]
SPBio_001400
STK632659
Spectrum2_001550
Spectrum3_001770
4BeractantapprovedPhase 4, Phase 2, Phase 315108778-82-1
5
Progesteroneapproved, vet_approvedPhase 4, Phase 3, Phase 255957-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
6
Atropineapproved, vet_approvedPhase 41365908-99-6, 51-55-8174174
Synonyms:
(+,-)-Tropyl tropate
(+-)-Atropine
(+-)-Hyoscyamine
(+-)-atropine
(+-)-hyoscyamine
(+/-)-Atropine
(+/-)-Hyoscyamine
(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
(3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane
(3-exo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
(±)-atropine
(±)-hyoscyamine
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI)
120-29-6
1alphaH,5alphaH-Tropan-3alpha-ol
1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester)
1alphaH,5alphaH-Tropan-3beta-ol
2-Phenylhydracrylic acid 3-alpha-tropanyl ester
51-55-8
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate
A0132_SIGMA
A2468_SIGMA
AC1L5AX3
AC1Q3XL2
ACon1_000046
AI3-60219
AKOS005137976
ATROPINE
Ambap120-29-6
Anaspaz
Atropair
Atropen
Atropen (TN)
Atropin
Atropin [German]
Atropin-flexiolen
Atropina
Atropina [Italian]
Atropine
Atropine (USP)
Atropine Care
Atropine Sulfate
Atropine Sulfate S.O.P.
Atropine [BAN]
Atropinol
Atropinum
Atropt
Atrosulf
BRD-A27290375-001-01-8
Belladenal
Bellergal-S
Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester
C01479
C17H23NO3
CAS-120-29-6
CCRIS 3080
CHEBI:15742
CHEBI:15884
CHEBI:16684
CHEBI:537621
CHEBI:57858
CHEMBL1235490
 
CID174174
CPD001906768
Cytospaz
D00113
DB00572
DB04026
DL-Hyoscyamine
DL-Tropanyl 2-hydroxy-1-phenylpropionate
DL-Tropyl tropate
EINECS 200-104-8
Eyesules
FT-0082634
HMS2089A16
HSDB 2199
Hyoscyamine sulfate
I-Tropine
Isopto Atropine
Isopto-atropine
LS-7203
MEGxp0_001878
MLS000069795
MLS001148094
MLS002695888
Minims
Minims Atropine
MolPort-001-742-593
MolPort-003-986-158
Mydriasine
NCGC00016370-01
NCGC00142514-01
NCGC00142514-03
NP-010662
Neo-Diophen
OR22908
Ocu-Tropine
Protamine & Atropine
SAM002554885
SMR000058248
ST057178
ST057655
T0534
TL8000018
Tropanol
Tropic acid, 3-alpha-tropanyl ester
Tropic acid, ester with tropine
Tropine (+/-)-tropate
Tropine tropate
Tropine, tropate (ester)
Troyl tropate
Urised
[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
a-Tropine
atropinium cation
atropinium(1+)
b eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]
beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]
bmse000649
d1-hyoscyamine
dl-Hyoscyamine
dl-Tropyltropate
dl-tropyltropate
endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
endo-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
hyoscyamine
nchembio.307-comp21
tropan-3alpha-ol
tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate
tropan-3beta-ol
7
RemifentanilapprovedPhase 4, Phase 1, Phase 2471132875-61-760815
Synonyms:
1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester
132539-07-2 (mono-hydrochloride)
132875-61-7
3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester
AC1L1TZ8
AC1Q5ZGR
BIDD:GT0029
C08021
CHEBI:8802
CHEMBL1005
CID60815
D08473
DB00899
 
DEA No. 9739
GI 87084B
GI 87084X
GI87084B
L001266
LS-115982
MolPort-004-286-006
REMIFENTANIL
Remifentanil (INN)
Remifentanil [INN:BAN]
Remifentanyl
UNII-P10582JYYK
Ultiva
Ultiva (TN)
methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
8
Caffeineapproved, NutraceuticalPhase 4, Phase 339658-08-22519
Synonyms:
07E4FB58-FD79-4175-8E3D-05BF96954522
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-Trimethylxanthine
1,3,7-trimethyl-2,6-dioxopurine
1,3,7-trimethylpurine-2,6-dione
1,3,7-trimethylxanthine
1-3-7-TRIMETHYLXANTHINE
1-Methyl-Theobromine
1-methyltheobromine
137X
1gfz
1l5q
1l7x
27602_FLUKA
2a3b
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
3,7-dihydro-1,3,7-trimethyl-1H-purine
5-26-13-00558 (Beilstein)
58-08-2
7-Methyl Theophylline
7-Methyltheophylline
7-methyltheophylline
71701-02-5
75035_FLUKA
95789-13-2
A.S.A. and Codeine Compound
AC-12774
AC1L1DV2
AC1Q3Z23
ACon1_000085
AI3-20154
AKOS000121334
Alert-Pep
Alert-pep
Anacin Maximum Strength
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anhydrous caffeine (TN)
Anoquan
BIDD:ER0554
BIDD:GT0632
BIDD:PXR0172
BIM-0050216.0001
BRD-K02404261-001-02-7
BRD-K02404261-001-03-5
BRN 0017705
BSPBio_001921
Berlin-Chemie Brand of Caffeine
Bio-0579
Bio1_000473
Bio1_000962
Bio1_001451
Bristol-Myers Squibb Brand of Caffeine
C 0750
C07481
C0750_SIAL
C1778_SIAL
C2042
C6035_FLUKA
C6035_SIGMA
C7731_SIAL
C8960_SIAL
CCRIS 1314
CFF
CHEBI:27732
CHEMBL113
CID2519
CU-01000012617-3
Cafamil
Cafcit
Cafecon
Cafeina
Cafergot
Cafeína
Caffedrine
Caffedrine Caplets
Caffein
Caffeina
Caffeina [Italian]
Caffeine (USP)
Caffeine (natural)
Caffeine Pure
Caffeine [BAN:JAN]
Caffeine solution
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeine, anhydrous
Caffeine, synthetic
Caffeinum
Caffine
Cafipel
Caféine
Coffein
Coffein [German]
Coffeine
Coffeinum
Coffeinum N
Coffeinum Purrum
Compound 65
D002110
D00528
DB00201
DHC Plus
DHCplus
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
DivK1c_000730
Durvitan
EINECS 200-362-1
EU-0100228
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA No. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline Brand of Caffeine
Guaranine
HMS1920I09
HMS2091O11
HMS502E12
HSDB 36
Hycomine
Hycomine Compound
I14-4386
 
IDI1_000730
Invagesic
Invagesic Forte
KBio1_000730
KBio2_001781
KBio2_004349
KBio2_006917
KBio3_001141
KBioGR_002325
KBioSS_001781
Keep Alert
Kofein
Kofein [Czech]
Koffein
Koffein [German]
L000155
LS-237
Lanorinal
Lopac-C-0750
Lopac0_000228
MEGxp0_001350
MLS001055341
MLS001056714
MLS001066409
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura Brand of Caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Midol Maximum Strength
Migergot
Miudol
MolMap_000054
MolPort-000-730-850
Monohydrate Caffeine
Monomethyl Derivative of Theophylline
Monomethyl derivative of Theophylline
NCGC00015208-01
NCGC00015208-02
NCGC00015208-04
NCGC00015208-14
NCGC00090699-01
NCGC00090699-02
NCGC00090699-03
NCGC00090699-04
NCGC00090699-05
NCGC00090699-06
NCGC00090699-07
NCGC00090699-08
NCGC00090699-09
NCGC00168808-01
NCGC00168808-02
NCI-C02733
NCIOpen2_008255
NINDS_000730
NSC 5036
NSC5036
Natural Caffeinum
Nix Nap
No Doz
No-Doz
Nodaca
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
Organex
Orphengesic
Orphengesic Forte
P-A-C Analgesic Tablets
PDSP1_001016
PDSP1_001235
PDSP2_001000
PDSP2_001219
Passauer Brand of Caffeine
Pep-Back
Percoffedrinol N
Percutafeine
Phensal
Pierre Fabre Brand of Caffeine
Probes1_000150
Probes2_000128
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick Pep
Quick-Pep
Refresh'n
Republic Drug Brand of Caffeine
SDCCGMLS-0064595.P001
SDCCGMLS-0064595.P002
SK 65 Compound
SK-65 Compound
SMR000326667
SPBio_001222
SPECTRUM1500155
STK177283
Seid Brand of Caffeine
Spectrum2_001261
Spectrum3_000321
Spectrum4_001782
Spectrum5_000423
Spectrum_001301
Stim
Synalgos-Dc
TNP00310
Thein
Theine
Theobromine ME
Theobromine Me
Theophylline ME
Theophylline Me
Theophylline, 7-methyl
Thompson Brand 1 of Caffeine
Thompson Brand 2 of Caffeine
Tirend
Tri-Aqua
Triad
UNII-3G6A5W338E
Ultra Pep-Back
Vivarin
W222402_ALDRICH
WLN: T56 BN DN FNVNVJ B1 F1 H1
Wake-Up
Wigraine
Xanthine, 1,3,7-trimethyl
ZINC00001084
bmse000206
cafeine
caffeine
caffenium
component of Cafergot
nchembio.243-comp7
nchembio.63-comp5
nchembio774-comp2
teina
teína
9HormonesPhase 4, Phase 3, Phase 2, Phase 114415
10Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 113180
11AlbuterolPhase 4429
12Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 113168
13Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
14Adrenergic AgonistsPhase 43027
15Adrenergic beta-2 Receptor AgonistsPhase 4957
16Adrenergic AgentsPhase 45352
17glucocorticoidsPhase 4, Phase 3, Phase 2, Phase 15103
18Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 123689
19Bronchodilator AgentsPhase 4, Phase 3, Phase 2, Phase 12965
20Autonomic AgentsPhase 4, Phase 3, Phase 2, Phase 110150
21Anti-Asthmatic AgentsPhase 4, Phase 3, Phase 2, Phase 13488
22Adrenergic beta-AgonistsPhase 41714
23Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
24Respiratory System AgentsPhase 4, Phase 3, Phase 2, Phase 14997
25Tocolytic AgentsPhase 4, Phase 3, Phase 2739
26Pulmonary SurfactantsPhase 4, Phase 3, Phase 2, Phase 1111
27Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 2, Phase 110729
28AnticoagulantsPhase 4, Phase 32623
29Caffeine citratePhase 4, Phase 320
30ProgestinsPhase 4, Phase 3, Phase 2564
31Purinergic P1 Receptor AntagonistsPhase 4, Phase 3360
32Phosphodiesterase InhibitorsPhase 4, Phase 3, Phase 21289
33Central Nervous System StimulantsPhase 4, Phase 32211
34AntibodiesPhase 4, Phase 36394
3511-hydroxyprogesteronePhase 4, Phase 2, Phase 332
36ImmunoglobulinsPhase 4, Phase 36394
37VaccinesPhase 46611
3817-alpha-hydroxy-progesterone caproatePhase 4, Phase 2, Phase 332
39Estrogen AntagonistsPhase 4, Phase 2, Phase 31349
40LactoferrinPhase 451
41EstrogensPhase 4, Phase 2, Phase 32542
42Calcium, DietaryPhase 45713
43Chelating AgentsPhase 41423
44Soy BeanNutraceuticalPhase 4554
45Omega 3 Fatty AcidNutraceuticalPhase 4, Phase 31018
46
Citric Acidnutraceutical, vet_approvedPhase 4, Phase 3, Phase 2116077-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
47CaproateNutraceuticalPhase 4, Phase 2, Phase 335
48CitrateNutraceuticalPhase 4, Phase 3, Phase 21160
49OliveNutraceuticalPhase 4278
50
Nitric OxideapprovedPhase 3, Phase 261710102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique

Interventional clinical trials:

(show top 50)    (show all 272)
idNameStatusNCT IDPhase
1Preterm Infant Inhaled Albuterol DosingUnknown statusNCT02447250Phase 4
2Surfactant Administration During Spontaneous BreathingUnknown statusNCT01329432Phase 4
3Prevention of Chronic Lung Disease (CLD) in Preterm InfantsUnknown statusNCT00883532Phase 4
4Early CPAP in Respiratory Distress SyndromeUnknown statusNCT00368680Phase 4
5The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary DysplasiaCompletedNCT00926276Phase 4
6Early Versus Late Lactoferrin in Prevention of Neonatal SepsisCompletedNCT02959229Phase 4
7Prevention of RSV Infections in Bone Marrow Transplant RecipientsCompletedNCT00001903Phase 4
8Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm DeliveryCompletedNCT00331695Phase 4
9Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part IVCompletedNCT01604447Phase 4
10Evaluate the Use of Plastic Bags in Preventing and Treating Hypothermia in NeonatesCompletedNCT01403623Phase 4
11OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAPRecruitingNCT02140580Phase 4
12Early Caffeine in Preterm NeonatesRecruitingNCT03086473Phase 4
13Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress SyndromeRecruitingNCT02164734Phase 4
14Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part IIIRecruitingNCT01604434Phase 4
15Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary DysplasiaActive, not recruitingNCT01039285Phase 4
16Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and MedialipideNot yet recruitingNCT02853253Phase 4
17Curosurf and Survanta Treatment(CAST)of RDS in Very Premature InfantsTerminatedNCT00767039Phase 4
18Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma HominisUnknown statusNCT01652118Phase 3
19Trial of Late Surfactant for Prevention of Bronchopulmonary DysplasiaUnknown statusNCT01022580Phase 3
20Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 gUnknown statusNCT02102711Phase 3
21Cysteine Supplementation in Critically Ill NeonatesUnknown statusNCT00254176Phase 2, Phase 3
22Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary DysplasiaCompletedNCT01035190Phase 3
23PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm NeonatesCompletedNCT00623740Phase 3
24Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm InfantsCompletedNCT00931632Phase 3
25Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary DysplasiaCompletedNCT01503801Phase 2, Phase 3
26Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary DysplasiaCompletedNCT00004785Phase 3
27Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV)CompletedNCT00433212Phase 3
28Inhaled Beclomethasone to Prevent Chronic Lung DiseaseCompletedNCT00000576Phase 3
29Post-Hospitalization Nursing Effectiveness (PHONE) StudyCompletedNCT00314431Phase 3
30Exosurf Neonatal and Survanta for Treatment of Respiratory Distress SyndromeCompletedNCT01203358Phase 2, Phase 3
31Inhaled NO in Prevention of Chronic Lung DiseaseCompletedNCT00000548Phase 3
32Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric OxideCompletedNCT00569530Phase 3
33Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature InfantsCompletedNCT00006401Phase 3
34Randomized Trial of Nasal Continuous Positive Airway Pressure or Synchronized Nasal Ventilation in Premature Infants.CompletedNCT00188968Phase 3
35Vitamin D Supplementation for Extremely Preterm InfantsCompletedNCT01600430Phase 2, Phase 3
36High Frequency Ventilation in Premature Infants (HIFI)CompletedNCT00000567Phase 3
37Premature Infants in Need of Transfusion (PINT)CompletedNCT00182390Phase 3
38Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian ChildrenCompletedNCT01006629Phase 2, Phase 3
39The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung DiseaseCompletedNCT00431418Phase 3
40Dexamethasone Therapy in VLBW Infants at Risk of CLDCompletedNCT00011362Phase 3
41Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature BabiesCompletedNCT00551642Phase 3
42A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm InfantsCompletedNCT02305160Phase 2, Phase 3
43Prolonged Outcomes After Nitric Oxide (PrONOx)CompletedNCT00234247Phase 3
44Safety Study of Home Oxygen Therapy for Children With Acute BronchiolitisCompletedNCT00677066Phase 3
45Intravenous Immunoglobulin in Prevention of Preterm Neonatal SepsisCompletedNCT02954926Phase 3
46PREGNANT Short Cervix TrialCompletedNCT00615550Phase 3
47Oxygen Toxicity in the Resuscitation in Extremely Premature InfantsCompletedNCT00494702Phase 3
48Caffeine for Apnea of Prematurity (CAP)CompletedNCT00182312Phase 3
49Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)CompletedNCT00009646Phase 3
50NIV Strategies for RDS in Preterm Infants. NIV (Non Invasive Ventilation), RDS (Respiratory Distress Syndrome)CompletedNCT02259400Phase 2, Phase 3

Search NIH Clinical Center for Bronchopulmonary Dysplasia

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Bronchopulmonary Dysplasia cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Bronchopulmonary Dysplasia:
PNEUMOSTEM

Genetic Tests for Bronchopulmonary Dysplasia

About this section

Anatomical Context for Bronchopulmonary Dysplasia

About this section

MalaCards organs/tissues related to Bronchopulmonary Dysplasia:

36
Lung, Endothelial, Brain, Neutrophil, Bone, Testes, Monocytes

LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Bronchopulmonary Dysplasia:
id TissueAnatomical CompartmentCell Relevance
1 LungAlveoliAlveolar Epithelial Type 1 Cells Potential therapeutic candidate, affected by disease
2 LungAlveoliAlveolar Epithelial Type 2 Cells Potential therapeutic candidate, affected by disease
3 LungPulmonary Capillary Plexus  Affected by disease

Publications for Bronchopulmonary Dysplasia

About this section

Articles related to Bronchopulmonary Dysplasia:

(show top 50)    (show all 708)
idTitleAuthorsYear
1
GSTP1 and CYP2B6 Genetic Polymorphisms and the Risk of Bronchopulmonary Dysplasia in Preterm Neonates. (28081574)
2017
2
Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes. (28067830)
2017
3
Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. (28079864)
2017
4
Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants. (27893721)
2017
5
Association between Hemoglobin Levels in the First 3 Days of Life and Bronchopulmonary Dysplasia in Preterm Infants. (27120476)
2016
6
How useful and feasible are early biochemical markers of bronchopulmonary dysplasia? (27062476)
2016
7
Mechanisms of Lung Injury and Bronchopulmonary Dysplasia. (27603539)
2016
8
A new look at bronchopulmonary dysplasia: postcapillary pathophysiology and cardiac dysfunction. (28090292)
2016
9
Differential expression of long non-coding RNAs in hyperoxia-induced bronchopulmonary dysplasia. (27137150)
2016
10
Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia. (27908648)
2016
11
Systemic Corticosteroids for the Prevention of Bronchopulmonary Dysplasia: Picking the Right Drug for the Right Baby. (27461202)
2016
12
An arginase-1 SNP that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia enhances NO-mediated apoptosis in lymphocytes. (27895230)
2016
13
Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia. (27142639)
2016
14
A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia. (26663142)
2016
15
Chorioamnionitis at birth does not increase the risk of neurodevelopmental disability in premature infants with bronchopulmonary dysplasia. (27552089)
2016
16
Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature. (27986502)
2016
17
Preeclampsia and the Risk of Bronchopulmonary Dysplasia in Preterm Infants Less Than 32 Weeks' Gestation. (27919118)
2016
18
Impact of bronchopulmonary dysplasia on brain and retina. (26988760)
2016
19
Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis. (27532916)
2016
20
Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. (27470692)
2016
21
Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. (27158330)
2016
22
MicroRNA in late lung development and bronchopulmonary dysplasia: the need to demonstrate causality. (27216745)
2016
23
Association of TLR polymorphisms with bronchopulmonary dysplasia. (27457283)
2016
24
Ascorbylperoxide Contaminating Parenteral Nutrition Is Associated With Bronchopulmonary Dysplasia or Death in Extremely Preterm Infants. (27036126)
2016
25
Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1Ra. (27482635)
2016
26
Vitamin D and bronchopulmonary dysplasia in preterm infants. (27467562)
2016
27
Post-Translational Modification of I^-Catenin is Associated with Pathogenic Fibroblastic Changes in Bronchopulmonary Dysplasia. (27941077)
2016
28
Pulmonary Vein Stenosis in Neonates with Severe Bronchopulmonary Dysplasia. (26862723)
2016
29
Postnatal growth restriction augments oxygen-induced pulmonary hypertension in a neonatal rat model of bronchopulmonary dysplasia. (27509009)
2016
30
Cardiac Mechanics in Children with Bronchopulmonary Dysplasia. (26506411)
2016
31
Commentary: A Breath of Fresh Air on the Mesenchyme: Impact of Impaired Mesenchymal Development on the Pathogenesis of Bronchopulmonary Dysplasia. (27066487)
2016
32
An Elevation of Serum Ferritin Level Might Increase Clinical Risk for the Persistence of Patent Ductus Arteriosus, Sepsis and Bronchopulmonary Dysplasia in Erythropoietin-Treated Very-Low-Birth-Weight Infants. (27547966)
2016
33
Where Are We Now with the Role of Steroids in the Management of Bronchopulmonary Dysplasia in Extremely Premature Babies? (27559539)
2016
34
Early Detection for Right Ventricular Dysfunction in Bronchopulmonary Dysplasia without Pulmonary Hypertension. (28090250)
2016
35
Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia. (27442155)
2016
36
Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis. (27940717)
2016
37
Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study. (27442157)
2016
38
Neurally Adjusted Ventilatory Assist in Preterm Infants With Established or Evolving Bronchopulmonary Dysplasia on High-Intensity Mechanical Ventilatory Support: A Single-Center Experience. (27918385)
2016
39
Prophylactic low-dose hydrocortisone treatment increases the rate of survival without bronchopulmonary dysplasia in extremely preterm infants. (27516373)
2016
40
Chorioamnionitis and subsequent bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year cohort. (27583395)
2016
41
Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia: Cornerstone of Care or Futile Therapy? (27147702)
2016
42
Association between Breast Milk and Bronchopulmonary Dysplasia: A Single Center Observational Study. (27487230)
2016
43
Antibiotic Exposure and Risk for Death or Bronchopulmonary Dysplasia in Very Low Birth Weight Infants. (27908652)
2016
44
Looking ahead: where to next for animal models of bronchopulmonary dysplasia? (27917436)
2016
45
Oxygen weaning after hospital discharge in children with bronchopulmonary dysplasia. (27093064)
2016
46
Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease. (27478373)
2016
47
Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants. (27117196)
2016
48
Expression of transforming growth factor-I^1 in neonatal rats with hyperoxia-induced bronchopulmonary dysplasia and its relationship with lung development. (27173325)
2016
49
Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia. (27957795)
2016
50
Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus. (27862302)
2016

Variations for Bronchopulmonary Dysplasia

About this section

Expression for genes affiliated with Bronchopulmonary Dysplasia

About this section
Search GEO for disease gene expression data for Bronchopulmonary Dysplasia.

Pathways for genes affiliated with Bronchopulmonary Dysplasia

About this section

Pathways related to Bronchopulmonary Dysplasia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.2CXCL8, IL1RN, TIMP1
29.1CXCL8, ITGAM, TIMP1
38.9CXCL8, ELANE, FLT1, ITGAM

GO Terms for genes affiliated with Bronchopulmonary Dysplasia

About this section

Cellular components related to Bronchopulmonary Dysplasia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1secretory granuleGO:00301419.5ELANE, SCGB1A1, SOD1
2extracellular exosomeGO:00700627.6ELANE, IL1RN, ITGAM, RBP4, RNASE3, SCGB1A1
3extracellular regionGO:00055766.6CXCL8, ELANE, FGF10, FLT1, IL1RN, RBP4
4extracellular spaceGO:00056155.9CXCL8, ELANE, FGF10, FLT1, IL1RN, ITGAM

Biological processes related to Bronchopulmonary Dysplasia according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1blood vessel morphogenesisGO:004851410.3FGF10, FLT1
2embryonic digestive tract developmentGO:004856610.2CXCL8, FGF10
3induction of positive chemotaxisGO:005093010.2CXCL8, FGF10
4female genitalia morphogenesisGO:004880710.2FGF10, RBP4
5positive regulation of vascular endothelial growth factor receptor signaling pathwayGO:003094910.2FGF10, FLT1
6chemotaxisGO:00069359.9CXCL8, FGF10, FLT1
7response to lipopolysaccharideGO:00324969.7ELANE, FGF10, SCGB1A1
8response to organic substanceGO:00100339.4SCGB1A1, SOD1, TIMP1
9neutrophil degranulationGO:00433129.0ELANE, ITGAM, RNASE3, SELL

Molecular functions related to Bronchopulmonary Dysplasia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1heparin bindingGO:00082019.6ELANE, FGF10, SELL
2protease bindingGO:00020209.2ELANE, SELL, TIMP1

Sources for Bronchopulmonary Dysplasia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet